Cerebrovascular accident in a child with precursor B-cell acute lymphoblastic leukemia and coronavirus disease 2019: a case report

Abstract

Background Coronavirus disease 2019 can lead to rare but severe and life-threatening diseases in susceptible high-risk populations, including patients with immunodeficiency. A rare event in this report is stroke following COVID-19 disease in a patient with an immunocompromised background due to leukemia and anti-cancer treatments. Case presentation A 6-year-old iranian girl with precursor B-cell leukemia receiving vincristine therapy presented with fever and absolute neutrophil count < 500. Her severe acute respiratory syndrome coronavirus 2 polymerase chain reaction test was positive. During hospitalization, she had abrupt onset tachypnea, reduced O2 saturation, and generalized tonic–clonic seizures treated with phenytoin and levetiracetam. Right parietal lobe ischemia was found on a brain computed tomography scan, and the cerebrospinal fluid polymerase chain reaction test was positive for severe acute respiratory syndrome coronavirus 2. Several days later, she developed lower extremity paralysis and speech impairment, so speech therapy and physiotherapy were initiated. The patient also received dexamethasone, mannitol, heparin, and remdesivir. She was discharged with enoxaparin and levetiracetam. Chemotherapy resumed 2 weeks following discharge. Her speech and walking improved after 10 months of follow-up, and bone marrow aspiration showed total remission. Conclusion Owing to the link between coronavirus disease 2019 and hematologic cancers with hypercoagulopathy and the tendency of patients with leukemia to have coronavirus disease 2019 complications, children with leukemia as well as suspected coronavirus disease 2019 must be hospitalized to prevent blood clot formation.

Two Cases of Acute Focal Bacterial Nephritis With Central Nervous System Manifestations in Children and Literature Review

“…It is also particularly important that Coronavirus disease 2019 can lead to rare but severe and life-threatening diseases in susceptible high-risk populations, including patients with immunodeficiency. A rare event in this report 19 is stroke following COVID-19 disease in a patient with an immunocompromised background due to leukemia and anti-cancer treatments. Both of our cases with AFBN were accompanied by high fever, disturbance of consciousness, and elevated inflammatory markers.…”

Seizure as a Manifestation of Fingolimod Rebound Syndrome: A Case Report and Literature Review

“…37 The report of infection and inflammation of the COVID-19 contributing to seizures and cerebrovascular accidents also confirms the role of neuroinflammation in this regard. 38 Suggested to be linked with synaptic function, the mTOR signaling pathway is thought to influence neuronal excitability, leading to epileptogenesis. 39 This finding indicates that the modulation of the mTOR signaling pathway might be an effective intervention in several kinds of epilepsy.…”

Mechanisms of pediatric ischemic strokes in COVID-19: a systematic review

“…In this systematic review, identified comorbidities include anemia (Appavu et al, 2021;Beslow et al, 2021;Español et al, 2022) hemoglobinopathies (Beslow et al, 2021;Sa et al, 2021), hematologic malignancies (Sánchez-Morales et al, 2021;Whitworth et al, 2021;Karimi et al, 2022), structural cardiovascular anomalies (Khoshnood et al, 2021;Sánchez-Morales et al, 2021), prior infection with varicella (Beslow et al, 2021), systemic and CNS bacterial and tuberculous infections (Essajee et al, 2020;de Marcellus et al, 2021;Fraser et al, 2022).…”